Literature DB >> 24214023

Celastrol from 'Thunder God Vine' protects SH-SY5Y cells through the preservation of mitochondrial function and inhibition of p38 MAPK in a rotenone model of Parkinson's disease.

Bong-Suk Choi1, Hyool Kim, Hyo Jeong Lee, Kumar Sapkota, Se Eun Park, Seung Kim, Sung-Jun Kim.   

Abstract

Celastrol, a potent natural triterpene and one of the most promising medicinal molecules, is known to possess a broad range of biological activity. Rotenone, a pesticide and complex I inhibitor, is commonly used to produce experimental models of Parkinson's disease both in vivo and in vitro. The present study was designed to examine the effects of celastrol on cell injury induced by rotenone in the human dopaminergic cells and to elucidate the possible mechanistic clues in its neuroprotective action. We demonstrate that celastrol protects SH-SY5Y cells from rotenone-induced cellular injury and apoptotic cell death. Celastrol also prevented the increased generation of reactive oxygen species and mitochondrial membrane potential (ΔΨm) loss induced by rotenone. Similarly, celastrol treatment inhibited cytochrome c release, Bax/Bcl-2 ratio changes, and caspase-9/3 activation. Celastrol specifically inhibited rotenone-evoked p38 mitogen-activated protein kinase activation in SH-SY5Y cells. These data suggest that celastrol may serve as a potent agent for prevention of neurotoxin-induced neurodegeneration through multiple mechanisms and thus has therapeutic potential for the treatment of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24214023     DOI: 10.1007/s11064-013-1193-y

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  44 in total

1.  Teaching old drugs new tricks. Meeting of the Neurodegeneration Drug Screening Consortium, 7-8 April 2002, Washington, DC, USA.

Authors:  Jill Heemskerk; Allan J Tobin; Lisa J Bain
Journal:  Trends Neurosci       Date:  2002-10       Impact factor: 13.837

Review 2.  Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae).

Authors:  Anita M Brinker; Jun Ma; Peter E Lipsky; Ilya Raskin
Journal:  Phytochemistry       Date:  2007-01-23       Impact factor: 4.072

Review 3.  How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?

Authors:  Jerry E Chipuk; Douglas R Green
Journal:  Trends Cell Biol       Date:  2008-03-07       Impact factor: 20.808

4.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease.

Authors:  R Betarbet; T B Sherer; G MacKenzie; M Garcia-Osuna; A V Panov; J T Greenamyre
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

5.  The triterpene celastrol as a very potent inhibitor of lipid peroxidation in mitochondria.

Authors:  H Sassa; Y Takaishi; H Terada
Journal:  Biochem Biophys Res Commun       Date:  1990-10-30       Impact factor: 3.575

6.  Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid.

Authors:  Jeong-Hyung Lee; Tae Hyeon Koo; Hyunkyung Yoon; Haeng Sun Jung; Hui Zi Jin; Kyeong Lee; Young-Soo Hong; Jung Joon Lee
Journal:  Biochem Pharmacol       Date:  2006-09-18       Impact factor: 5.858

Review 7.  Mitochondrial biology and Parkinson's disease.

Authors:  Celine Perier; Miquel Vila
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

8.  Celastrol inhibits pro-inflammatory cytokine secretion in Crohn's disease biopsies.

Authors:  Guillaume F Pinna; Marc Fiorucci; Jean-Marie Reimund; Nathalie Taquet; Yves Arondel; Christian D Muller
Journal:  Biochem Biophys Res Commun       Date:  2004-09-24       Impact factor: 3.575

9.  Suppression of inflammatory responses by celastrol, a quinone methide triterpenoid isolated from Celastrus regelii.

Authors:  D H Kim; E K Shin; Y H Kim; B W Lee; J-G Jun; J H Y Park; J-K Kim
Journal:  Eur J Clin Invest       Date:  2009-06-22       Impact factor: 4.686

10.  Celastrols as inducers of the heat shock response and cytoprotection.

Authors:  Sandy D Westerheide; Joshua D Bosman; Bessie N A Mbadugha; Tiara L A Kawahara; Gen Matsumoto; Soojin Kim; Wenxin Gu; John P Devlin; Richard B Silverman; Richard I Morimoto
Journal:  J Biol Chem       Date:  2004-10-26       Impact factor: 5.486

View more
  25 in total

1.  Development of EBV-encoded small RNA targeted PCR to classify EBV positive diffuse large B-cell lymphoma (DLBCL) of the elderly.

Authors:  Jaewang Lee; Min Park; Min Ho Lee; Hyun Jun Woo; Hyun-Woo Kim; Ji Yeong Yang; Yong-Bin Eom; Sa-Hyun Kim; Changyoung Yoo; Jong-Bae Kim
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

2.  Induction of heat shock proteins in differentiated human neuronal cells following co-application of celastrol and arimoclomol.

Authors:  Catherine A S Deane; Ian R Brown
Journal:  Cell Stress Chaperones       Date:  2016-06-08       Impact factor: 3.667

3.  Neuroprotective Effects of Echinacoside on Regulating the Stress-Active p38MAPK and NF-κB p52 Signals in the Mice Model of Parkinson's Disease.

Authors:  Jingsi Zhang; Zhennian Zhang; Jun Xiang; Min Cai; Zhonghai Yu; Xiangting Li; Ting Wu; Dingfang Cai
Journal:  Neurochem Res       Date:  2016-12-15       Impact factor: 3.996

4.  Celastrol-induced apoptosis in human nasopharyngeal carcinoma is associated with the activation of the death receptor and the mitochondrial pathway.

Authors:  Heng-Fu Lin; Ming-Ju Hsieh; Yi-Ting Hsi; Yu-Sheng Lo; Yi-Ching Chuang; Mu-Kuan Chen; Su-Yu Chien
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

5.  Celastrus paniculatus Willd. mitigates t-BHP induced oxidative and apoptotic damage in C2C12 murine muscle cells.

Authors:  Kandikattu Hemanth Kumar; M P Venuprasad; G V Jayashree; P Rachitha; K Krupashree; Ajay Pal; Farhath Khanum
Journal:  Cytotechnology       Date:  2014-08-15       Impact factor: 2.058

6.  Taxodione and arenarone inhibit farnesyl diphosphate synthase by binding to the isopentenyl diphosphate site.

Authors:  Yi-Liang Liu; Steffen Lindert; Wei Zhu; Ke Wang; J Andrew McCammon; Eric Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-09       Impact factor: 11.205

7.  Celastrol prevents cadmium-induced neuronal cell death by blocking reactive oxygen species-mediated mammalian target of rapamycin pathway.

Authors:  Ruijie Zhang; Nana Zhang; Hai Zhang; Chunxiao Liu; Xiaoqing Dong; Xiaoxue Wang; Yu Zhu; Chong Xu; Lei Liu; Sijun Yang; Shile Huang; Long Chen
Journal:  Br J Pharmacol       Date:  2016-11-21       Impact factor: 8.739

8.  Celastrol suppresses experimental autoimmune encephalomyelitis via MAPK/SGK1-regulated mediators of autoimmune pathology.

Authors:  Shivaprasad H Venkatesha; Kamal D Moudgil
Journal:  Inflamm Res       Date:  2019-02-28       Impact factor: 4.575

9.  Celastrol and Its Role in Controlling Chronic Diseases.

Authors:  Shivaprasad H Venkatesha; Kamal D Moudgil
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

10.  Celastrol pretreatment as a therapeutic option against cisplatin-induced nephrotoxicity.

Authors:  Tugce Boran; Aysenur Gunaydin; Ayse Tarbin Jannuzzi; Eren Ozcagli; Buket Alpertunga
Journal:  Toxicol Res (Camb)       Date:  2019-07-31       Impact factor: 3.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.